UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 351

Sortiert nach

Inhibitory effects of fruit juices on CYP3A activity

Drug metabolism and disposition, 2006-04, Vol.34 (4), p.521

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions

Journal of pharmaceutical sciences, 2017-09, Vol.106 (9), p.2368-2379

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1676-1686

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study

Clinical therapeutics, 2019-05, Vol.41 (5), p.961-971

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Journal of clinical pharmacology, 2021-07, Vol.61 (7), p.913-922

2021

Link zum Volltext

Verfügbarkeit prüfen

Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis

Journal of clinical pharmacology, 2021-12, Vol.61 (12), p.1567-1578

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Drug–Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically‐Based Pharmacokinetic Modelling

Basic & clinical pharmacology & toxicology, 2018-03, Vol.122 (3), p.331-340

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification and functional characterization of CYP4V2 genetic variants exhibiting decreased activity of lauric acid metabolism

Annals of human genetics, 2020-09, Vol.84 (5), p.400-411

2020

Link zum Volltext

Verfügbarkeit prüfen

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Blood, 2010-05, Vol.115 (18), p.3827-3834

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6558-6567

2016

Link zum Volltext

Verfügbarkeit prüfen

A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD‐EPI estimation

Journal of clinical pharmacy and therapeutics, 2019-10, Vol.44 (5), p.750-759

2019

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis

Scientific reports, 2022-08, Vol.12 (1), p.13395-13395, Article 13395

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features

PloS one, 2022-01, Vol.17 (1), p.e0262545-e0262545

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A)

Annals of human genetics, 2021-03, Vol.85 (2), p.80-91

2021

Link zum Volltext

Verfügbarkeit prüfen

Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research

British journal of clinical pharmacology, 2022-03, Vol.88 (3), p.1159-1169

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3096-3105

2016

Link zum Volltext

Verfügbarkeit prüfen

Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3

Journal of clinical pharmacology, 2019-06, Vol.59 (6), p.880-889

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of rifampin on enantioselective disposition and anti‐hypertensive effect of benidipine

British journal of clinical pharmacology, 2019-04, Vol.85 (4), p.737-745

2019

Link zum Volltext

Verfügbarkeit prüfen

clinical significance of the cytochrome P450 2C19 genetic polymorphism

Clinical pharmacokinetics, 2002, Vol.41 (12), p.913-958

2002

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring

Biomedicine & pharmacotherapy, 2023-02, Vol.158, p.114187-114187, Article 114187

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time

Journal of clinical pharmacology, 2018-10, Vol.58 (10), p.1347-1360

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS

Molecules (Basel, Switzerland), 2022-12, Vol.27 (23), p.8607

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis

International journal of infectious diseases, 2022-04, Vol.117, p.8-14

2022

Link zum Volltext

Verfügbarkeit prüfen

Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management

Pharmaceutics, 2022-05, Vol.14 (5), p.990

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects

Clinical pharmacology in drug development, 2018-08, Vol.7 (6), p.613-620

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(279)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(233)
Humans
(206)
Pharmacology & Pharmacy
(152)
Male
(94)
Adult
(81)
Pharmacology
(80)
Biological And Medical Sciences
(69)
Medical Sciences
(68)
Female
(65)
Pharmacology. Drug Treatments
(56)
Genotype
(43)
Middle Aged
(43)
Biochemistry & Molecular Biology
(36)
Pharmacokinetics
(29)
Asian Continental Ancestry Group - Genetics
(28)
Cross-Over Studies
(27)
Young Adult
(27)
Chemistry
(25)
Pharmaceutical Science
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Inhibitory effects of fruit juices on CYP3A activity

Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions

Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population

Pharmacokinetics of Single Doses of BI 425809 in Healthy Chinese and Japanese Subjects: A Randomized Study

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis

Prediction of Drug–Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically‐Based Pharmacokinetic Modelling

Identification and functional characterization of CYP4V2 genetic variants exhibiting decreased activity of lauric acid metabolism

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family

A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD‐EPI estimation

Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis

Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features

Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A)

Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research

Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake

Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3

Effect of rifampin on enantioselective disposition and anti‐hypertensive effect of benidipine

clinical significance of the cytochrome P450 2C19 genetic polymorphism

Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring

Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time

Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS

Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis

Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management

Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects

Suchergebnisse filtern